Erratum: Immune maintenance in glaucoma: Boosting the body's own neuroprotective potential (Journal of Ocular Biology, Diseases, and Informatics DOI 10.1007/s12177-009-9025-7);Immune maintenance in glaucoma: Boosting the body's own neuroprotective potential

Journal of Ocular Biology, Diseases, and Informatics

Volumn 2, Issue 2, 2009, Pages 73-77

  Schwartz, Michal ^a   London, Anat ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

"Protective autoimmunity"; Glaucoma; Macrophages; Neurodegenerative diseases; Neuroprotection; Therapeutic vaccination

Indexed keywords

GLATIRAMER;

AUTOIMMUNITY; DEGENERATIVE DISEASE; GLAUCOMA; HUMAN; IMMUNIZATION; INTRAOCULAR PRESSURE; MULTIPLE SCLEROSIS; NEUROPROTECTION; PRIORITY JOURNAL; RETINA GANGLION CELL; SHORT SURVEY; VACCINATION;

EID: 68949214290     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-009-9037-3     Document Type: Erratum

References (48)

1. HA Quigley AE Maumenee 1979 Long-term follow-up of treated open-angle glaucoma Am J Ophthalmol 87 4 519 525
2. MA Kass et al. 2002 The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch Ophthalmol 120 6 701 713 discussion 829-30
3. MC Leske et al. 2003 Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial Arch Ophthalmol 121 1 48 56
4. EC Johnson et al. 2006 The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models Exp Eye Res 83 1 51 60
5. RW Nickells et al. 2007 Surgical lowering of elevated intraocular pressure in monkeys prevents progression of glaucomatous disease Exp Eye Res 84 4 729 736
6. A Heijl et al. 2002 Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 10 1268 1279
7. JL Jay D Allan 1989 The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease Eye 3 Pt 5 528 535
8. K Nouri-Mahdavi et al. 1995 Outcomes of trabeculectomy for primary open-angle glaucoma Ophthalmology 102 12 1760 1769
9. RF Brubaker 1996 Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture Am J Ophthalmol 121 5 473 483
10. H Oku et al. 1997 Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit Invest Ophthalmol Vis Sci 38 12 2540 2544
11. H Levkovitch-Verbin et al. 2000 RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection Invest Ophthalmol Vis Sci 41 13 4169 4174
12. G Tezel 2006 Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences Prog Retin Eye Res 25 5 490 513
13. JW Olney 1969 Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion J Neuropathol Exp Neurol 28 3 455 474
14. JW Olney et al. 1986 The role of specific ions in glutamate neurotoxicity Neurosci Lett 65 1 65 71
15. SJ McKinnon 1997 Glaucoma, apoptosis, and neuroprotection Curr Opin Ophthalmol 8 2 28 37
16. ZN Oltvai SJ Korsmeyer 1994 Checkpoints of dueling dimers foil death wishes Cell 79 2 189 192
17. LA Levin et al. 1997 Identification of the bcl-2 family of genes in the rat retina Invest Ophthalmol Vis Sci 38 12 2545 2553
18. NA Thornberry 1998 Caspases: key mediators of apoptosis Chem Biol 5 5 R97 R103
19. NA Thornberry Y Lazebnik 1998 Caspases: enemies within Science 281 5381 1312 1316
20. HA Quigley 1999 Neuronal death in glaucoma Prog Retin Eye Res 18 1 39 57
21. M Schwartz 2005 Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all? J Glaucoma 14 4 321 323
22. Masters C, Wyss-Coray T, Pasinetti GM. Anti-inflammatory drugs fall short in Alzheimer's disease. Nat Med, 2008;14:916.
23. E Yoles et al. 2001 Protective autoimmunity is a physiological response to CNS trauma J Neurosci 21 11 3740 3748
24. J Kipnis et al. 2001 Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response J Neurosci 21 13 4564 4571
25. S Bakalash et al. 2003 Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma Invest Ophthalmol Vis Sci 44 3374 3381
26. G Moalem et al. 1999 Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy Nat Med 5 1 49 55
27. H Schori et al. 2001 Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma Proc Natl Acad Sci U S A 98 6 3398 3403
28. H Schori E Yoles M Schwartz et al. 2001 T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system J Neuroimmunol 119 2 199 204
29. + T cells Eur J Immunol 34 12 3434 3445
30. E Hauben et al. 2000 Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion J Neurosci 20 17 6421 6430
31. E Hauben M Schwartz 2003 Therapeutic vaccination for spinal cord injury: helping the body to cure itself Trends Pharmacol Sci 24 7 12
32. J Fisher et al. 2001 Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies J Neurosci 21 1 136 142
33. T Mizrahi E Hauben M Schwartz 2002 The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis J Immunol 169 5971 5977
34. J Kipnis et al. 2000 T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies Proc Natl Acad Sci U S A 97 13 7446 7451
35. J Kipnis M Schwartz 2002 Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders Trends Mol Med 8 319 323
36. EJ Benner et al. 2004 Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease Proc Natl Acad Sci U S A 101 25 9435 9440
37. M Schwartz 2007 Modulating the immune system: a vaccine for glaucoma? Can J Ophthalmol 42 3 439 441
38. G Moalem et al. 2000 Autoimmune T cells retard the loss of function in injured rat optic nerves J Neuroimmunol 106 1-2 189 197
39. O Butovsky E Hauben M Schwartz 2001 Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7-2 (CD86) and prevention of cyst formation FASEB J 15 6 1065 1067
40. R Barouch M Schwartz 2002 Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity FASEB J 16 1304 1306
41. O Butovsky et al. 2005 Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective Mol Cell Neurosci 29 3 381 393
42. I Shaked et al. 2005 Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators J Neurochem 92 997 1009
43. Shechter R, et al. Infiltrating blood-derived macrophages: vital immunoregulatory cells in spinal cord repair. Plos Med. 2009 (in press).
44. + regulatory T cells suppress the ability to withstand injury to the central nervous system Proc Natl Acad Sci U S A 99 15620 15625
45. + regulatory T-cell activity: implications for neurodegeneration J Neurosci 24 6133 6143
46. Y Ziv et al. 2006 Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood Nat Neurosci 9 2 268 275
47. A Rolls et al. 2007 Toll-like receptors modulate adult hippocampal neurogenesis Nat Cell Biol 9 9 1081 1088
48. R Shechter et al. 2008 Toll-like receptor 4 restricts retinal progenitor cell proliferation J Cell Biol 183 3 393 400